Good Life Advisors LLC Invests $339,000 in The Clorox Company (NYSE:CLX)

Good Life Advisors LLC purchased a new stake in The Clorox Company (NYSE:CLX) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,080 shares of the company’s stock, valued at approximately $339,000.

A number of other large investors have also recently added to or reduced their stakes in CLX. nVerses Capital LLC bought a new position in shares of Clorox during the third quarter worth about $1,075,000. Culbertson A N & Co. Inc. lifted its holdings in Clorox by 173.1% during the 3rd quarter. Culbertson A N & Co. Inc. now owns 9,443 shares of the company’s stock worth $1,538,000 after buying an additional 5,985 shares during the last quarter. Vontobel Holding Ltd. grew its position in shares of Clorox by 4.6% in the 3rd quarter. Vontobel Holding Ltd. now owns 27,213 shares of the company’s stock worth $4,433,000 after acquiring an additional 1,189 shares in the last quarter. ERn Financial LLC bought a new stake in shares of Clorox in the 3rd quarter valued at approximately $224,000. Finally, Creative Planning raised its position in shares of Clorox by 7.4% during the 3rd quarter. Creative Planning now owns 29,089 shares of the company’s stock valued at $4,739,000 after acquiring an additional 1,996 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.51% of the company’s stock.

Analyst Ratings Changes

CLX has been the subject of several recent research reports. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Citigroup increased their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Wells Fargo & Company decreased their target price on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research note on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft increased their price target on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Finally, BNP Paribas upgraded Clorox to a “strong sell” rating in a research report on Friday, September 6th. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $150.14.

Clorox Stock Performance

Shares of CLX opened at $161.96 on Friday. The firm has a market capitalization of $20.11 billion, a PE ratio of 83.92, a P/E/G ratio of 3.19 and a beta of 0.41. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The firm has a 50-day moving average price of $159.28 and a 200 day moving average price of $145.15. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.09.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. On average, sell-side analysts anticipate that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.01%. Clorox’s dividend payout ratio (DPR) is 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.